CDKN1C and Hyperinsulinemia: In BWS, imprinting defects lead to loss of expression of cell-cycle inhibitor CDKN1C (p57Kip2), resulting in unchecked beta cell expansion and excessive beta cell mass, which causes hyperinsulinemia, and hypoglycemia (140).